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Abstract
Cluster detection is an important public health endeavor and in this paper we describe and apply a 
recently developed Bayesian method. Commonly-used approaches are based on so-called scan 
statistics and suffer from a number of difficulties including how to choose a level of significance 
and how to deal with the possibility of multiple clusters. The basis of our model is to partition the 
study region into a set of areas which are either “null” or “non-null”, the latter corresponding to 
clusters (excess risk) or anti-clusters (reduced risk). We demonstrate the Bayesian method and 
compare with a popular existing approach, using data on breast, brain, lung, prostate and 
colorectal cancer, in the Puget Sound region of Washington St ate. We address the important issues 
of sensitivity to the priors, and the incorporation of covariates. The approach is implemented 
within the freely-available R package SpatialEpi.
Introduction
Cluster detection has a long and controversial history in epidemiology. Unfortunately, only 
very rarely have etiological insights been made as a result of investigations into clustering 
and clusters1 which has led Rothman2 to call this endeavor into question. Neutra,3 in a 
response to Rothman, agreed with a number of his conclusions but believed that 
investigation of putative clusters was a necessary part of the public health response; cluster 
detection can aid in identification of areas in need of resources or interventions such as 
public awareness campaigns and screening.
In this paper, we describe a new approach to cluster detection, based on a Bayesian model, 
and describe the use of the method for cluster detection for five cancers in the Puget Sound 
region of Washington State. First, we briefly review a number of the previous approaches to 
cluster detection that have been proposed. The most popular approaches are based on scan 
statistics, in which a circular window is passed over the study region and the significance of 
the observed number of cases in the window is determined. Different proposals base the 
circle size on distance,4 the number of cases5 and on the population.6 The latter method has 
been extensively refined and forms the basis of the method implemented in the SatScan 
software (http://www.satscan.org/.7) The model behind this approach assumes circular 
clusters are centered on each of the n area centroids. Circles with varying radii, up to a 
maximum that gives a circle with no more than a certain proportion of the total population 
(20% is a common choice) are considered. We refer to the circles as (single) zones. Hence, 
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any one area will typically fall within a large number of potential zones. Hypothesis testing 
is used to determine the significance of clusters by comparing the observed and expected 
numbers of disease under the null hypothesis. In the version relevant to the application 
considered here, a Poisson likelihood is assumed and a likelihood ratio statistic is calculated 
for each zone, with the null corresponding to no clusters. This approach clearly leads to a 
large number of dependent tests, and the multiplicity problem is circumvented by evaluating 
the significance of only the maximum of the likelihood ratio statistics over all circles, using 
a Monte Carlo p-value. The Monte Carlo p-value is computed by comparing the observed 
test statistic to a simulated null distribution. Each instance of the simulated null distribution 
is constructed by randomly assigning cases to locations under the null hypothesis of no 
clusters and computing the test statistic.
There are a number of drawbacks to the SatScan method. First, as with all frequentist testing 
procedures, a fundamental problem is how to interpret the resultant p-value and in particular 
choose a threshold below which “significance” should be declared. These difficulties are 
well-documented.8–10 A specific problem with p-values is that their interpretation critically 
depends on the power of the study. In the context of cluster detection, α = 0.05 was used in 
both Kulldorff et al.11 and Jemal et al.12 In the former, breast cancer was examined over 245 
counties of the North East of the US with 58,943 deaths and a population of 29,535,216. In 
the latter, prostate cancer was examined in males in the United States in 1970–1989 with 
71,692 black deaths and 382,204 white deaths amongst the total US male population. 
Consequently, the power is very different in the two studies but there is no explicit 
consideration of power in the calculation and interpretation of p-values; stated more bluntly, 
there is no balancing of type I and type II errors. Intuitively, the p-value significance 
threshold should decrease as the sample size increases since the power is increasing, i.e. the 
type II error is decreasing, and so the type I error should be decreasing also. A Bayesian 
approach to inference acknowledges that the type I and type II errors should go to zero and 
provides the machinery to avoid these problems. The standard Bayesian way to evaluate the 
evidence in the data for particular null and alternative hypotheses H0 and HA is the Bayes 
factor, given by p(data|H0)/p(data|HA). The numerator and denominator of the Bayes factor 
represent, respectively, the probability density of the data under the null and alternative 
hypotheses, and these calculations depend on the assumed model. The Bayes factor accounts 
for power through its denominator, and type I and type II errors are naturally balanced in the 
numerator and denominator.9;10;13
A second difficulty with the SatScan method is how to deal with the possibility of multiple 
clusters. The original version of the Kulldorff method, simply compared the p-values of the 
second, third, etc. most significant zones using the reference distribution for the maximum 
(most likely) cluster, after discarding those with overlap with the first cluster. This approach 
is therefore not using the correct reference distribution. The most recent multiple cluster 
version of the Kulldorff method14 removes the significant zone, and then repeats the 
procedure now using a new reference distribution, until no more significant zones are found. 
A deficiency of this approach is that the p-values are not directly comparable since they are 
based on different sample sizes and hence have different power. Also, since the procedure 
removes significant clusters from the study region at each iteration, the significance of 
secondary clusters must be interpreted as conditional on all previously identified significant 
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clusters and not as standalone measures as is desired. Furthermore, one should also consider 
the multiple testing aspect of the multiple comparisons that are being made but it would be 
very difficult to determine the appropriate error rate of the overall sequential procedure just 
described.14
We briefly describe previous approaches to Bayesian cluster detection. The usual smoothing 
of rates or relative risks, as implemented in common disease mapping models,15 is not a 
good idea, as clusters may be attenuated due to the shrinkage of these models.16 We have 
previously described our model for cluster detection17 and illustrated its use with the classic 
upstate New York leukemia dataset.18
In this paper we make some modest extensions to the methodology and demonstrate the 
approach in a more extensive application. Specifically, we apply the models to data on 
female breast, brain, lung, male prostate, and colorectal cancer, collected in the Puget Sound 
region of Washington State between 1996–2005. We choose breast, lung, prostate and 
colorectal because they are relatively common, while brain is relatively rare and so was 
picked to give an example of the methodology for a rarer cancer. Geographical analyses have 
also revealed excess brain cancer mortality in the northwest of the United States,19;20 a 
region that contains our study region. The results for breast cancer require careful 
interpretation and so we detail these in the main paper, while for brain cancer interpretation 
is more straightforward, and we include this in the paper as a contrast. The results for the 
remaining three cancer sites are presented in the Supplementary Materials. Our approach is 
most similar to that described by Gangnon and Clayton21–23 though with differences 
described elsewhere.17 We have implemented our method in the R computing environment 
within the SpatialEpi package.
Brain and Breast Cancer in Western Washington
Study Details
The Cancer Surveillance System (CSS) collects population-based data on cancer incidence 
and survival in n = 887 census tracts in 13 counties in western Washington State: Clallam, 
Grays Harbor, Island, Jefferson, King, Kitsap, Mason, Pierce, San Juan, Skagit, Snohomish, 
Thurston, and Whatcom counties. The CSS is a project of the Program in Epidemiology, 
Division of Public Health Sciences, at the Fred Hutchinson Cancer Research Center 
(FHCRC) and is part of the Surveillance, Epidemiology, and End Results (SEER)24 program 
of the National Cancer Institute which monitors cancer incidence and survival in 
approximately 26% of the US population. The CSS also provides data to the Washington 
State Cancer Registry, which monitors cancer incidence in the entire state of Washington.25 
In Figure 1 we present a map of the study region with the Seattle and Tacoma metropolitan 
regions highlighted with solid and dashed lines respectively and the city of Mount Vernon 
marked with a dot. All subsequent maps will include focused maps of both Seattle and 
Tacoma. Furthermore all values in legends are grouped by the Jenks natural breaks 
classification method which maximizes the variance between the group means while 
minimizing the within-group variance of values.26
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One must bear in mind that two of the chief reasons for carrying out a cluster detection 
endeavor are to discover previously unknown exposures or risk factors that are linked with 
clusters, or to detect areas with high risks (perhaps due to inaccessibility to health care) in 
order to prioritize public health resources and interventions (encouragement of screening, for 
example). If we are interested in the former, then adjustment for as many known risk factors 
as possible is merited. If we are interested in the latter, then we would not want to adjust for 
area-level variables such as income, since this will mask important differences. In the study 
we present here, we are interested in detecting areas with high residual (i.e. after adjustment 
for risk factors) risk and we report results with and without adjustment for an area-level 
measure of income.
As notation we will use yij to represent the disease count in each area i = 1, …, n and 
confounder stratum j = 1,…, J, with Nij the corresponding population size. For each cancer 
site, counts of disease incidence yij were obtained for each census tract i = 1,…, 887 
stratified by j = 1,…, 180 strata: age (18 age bands: 0–4, 5–9, 10–14, …, 75–79, 80–84, 
85+), race (5 categories: White, Black, Asian/Pacific Islander, American Indian and other 
including those of two or more races) and gender for brain, lung, and colorectal cancers, 
while we only consider women for breast cancer and men for prostate cancer. These disease 
counts were combined across years and paired with corresponding population counts Nij 
obtained from the 2000 Decennial Census. For each of the five cancer sites, we calculate two 
sets of expected numbers in area i, denoted Ei, using internal standardization, at the level of 
the census tract. In one set we adjust for age, race, and gender (when required) and in the 
other set we additionally adjust for income by quintile. We consider 1999 per capita income 
as reported by the American Community Survey at the census tract level only, since age, 
race, and gender stratified income data are not available. Our analysis will consider income 
through the quintiles defined by cutoffs $18,478, $21,661, $24,825, and $30,161. The 
income adjusted reference rates of disease for census tract i are based on disease and 
population counts from census tracts in the same income bracket. The Standardized 
Morbidity Ratio (SMR) in census tract i is calculated as SMRi = yi/Ei. The SMR is an area-
based summary and an estimate of the relative risk in an area, when compared to the 
reference rates that were used to construct the expected numbers.
Table 1 displays summaries of the aggregated disease counts yi for all 5 cancers, along with 
expected numbers Ei and standardized morbidity ratios SMRi, across areas i = 1,…, n, 
unadjusted and adjusted for income. Breast is the most common cancer, followed by 
prostate, lung, colorectal, and brain. We now present detailed analyses for brain and breast 
cancer, with lung, colorectal and prostate discussed in the Supplementary Materials.
Initial Analysis for Brain Cancer
Before a cluster detection exercise is carried out it is important to have knowledge of known 
risk factors, but the cause of many brain cancer cases is unknown (http://www.cancer.gov/
cancertopics/types/breast). Previously, there was evidence of excess brain cancer mortality in 
the northwest United States, as revealed in a cancer mortality atlas,19 and this was followed 
up with a formal study of brain cancer mortality across the United States from 1986–1995 
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using, amongst other statistical techniques, SatScan.20 This study reported evidence of a 
cluster in Washington State.
For our study the expected numbers for brain cancer incidence are displayed in Figure 2, 
with the left and right columns being unadjusted and adjusted for income, respectively. The 
corresponding SMRs are displayed in Figure 3. Compared to the other cancers the expected 
numbers are relatively small, but the SMRs show large variability, which may of course be 
attributed to sampling variability due to the relatively small expected numbers for many 
census tracts. A plot of (log) SMRs versus income quintile (both with and without 
adjustment for income), provided in the Supplementary Materials, shows very little evidence 
of a census tract level association between relative risk and income.
We present results of the multiple cluster Kulldorff method14 using both income unadjusted 
and adjusted expected counts. We set the highest proportion of the population a zone can 
contain at 15%, the α-cutoff to declare significance at α = 0.05 and simulate 9,999 Monte 
Carlo realizations under the null hypothesis of no clusters. The results are presented in 
Figure 4. For both income unadjusted and adjusted expected counts, there are no clusters 
that are significant at the 5% level.
Initial Analysis for Breast Cancer
We first briefly summarize the risk factors for breast cancer, leaning heavily on http://
www.cancer.gov/cancertopics/types/breast. The lifetime risk for developing breast cancer for 
women in the United States is approximately 1 in 8. Risk factors for breast cancer include 
genetic alterations, dense breasts, exposure to estrogen (early menstruation, late menopause, 
no pregnancy or late pregnancy), family history of breast cancer, alcohol, race (breast cancer 
is diagnosed more in white women) and obesity. Protective factors for breast cancer include 
less exposure to estrogen (for example through early pregnancy, breast-feeding, increased 
number of births and increased duration of breast feeding) and exercise.
The geographical distribution of breast cancer risk has received a reasonable amount of 
interest with Kulldorff et al.11 providing an early example of the application of a scan 
statistic to breast cancer, with numerous other studies following. For example, scan statistics 
have been used to detect clusters for breast cancer in Massachusetts,27 Texas,28 
Connecticut,29 and across all counties in the United States30. An interpretation of 
geographical variation across the United States has also been carried out,31 with a major 
conclusion being that at large scales at least, there are differences in presentation (i.e. stage) 
by region and by race. A large number of geographical analyses have examined the 
association between clusters and environmental pollution sources (see for example Jacquez 
and Greiling32 and references there-in). Interest in cluster detection for breast cancer extends 
beyond the United States, for example, breast cancer has been examined geographically in 
Japan, using the Kulldorff scan statistic.33
The expected numbers for breast cancer are displayed in Figure 5 with the SMRs displayed 
in Figure 6. The expected numbers for breast cancer are far greater than for brain and while 
the SMRs for breast cancer have roughly the same range as with brain, the former are more 
accurately estimated given the larger expected counts. In the Supplementary Materials we 
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plot the (log) SMRs (without adjustment for income) versus income quintiles, and we see 
that there is a negative association, with areas in higher income quintiles having higher 
relative risks. This is not unexpected given the above risk factors for breast cancer since we 
would expect women living in areas with low average income to have more and earlier 
pregnancies and a greater duration of breast feeding.
Figure 7 gives the results of the scan statistic both without and with adjustment for income. 
Without income there is one very large cluster in Seattle that has a significance level < 
0.0001, with three additional clusters, one to the west of Seattle, one in Tacoma and a single 
census tract near Mt Vernon in the north of the study region. With adjustment for income 
there are three areas, two in Tacoma with estimated relative risks of 5.671 and 2.320, and a 
third consisting of the single census tract near Mt Vernon with an estimated relative risk 
1.146.
A Bayesian Cluster Detection Model
As with the scan statistic method, suppose the study region is partitioned into i = 1,…, n 
areas, which are typically administrative subdivisions of a region such as census tracts, zip 
codes, or counties. Let θi be the relative risk in area i, where relative is with respect to the 
reference rates for disease that were used to construct the expected numbers. The 
Supplementary Materials contain a mathematical description of our model; here we give an 
explanation in heuristic terms.
Configurations as Data Models
Following Kulldorff6 we define what we refer to as single zones: contiguous collections of 
areas that form “jagged circles.” We create the list of single zones by sequentially 
aggregating neighboring areas, by taking each area in turn, and continually adding the areas 
whose centroids are closest to the area center. This procedure is continued until the zone’s 
population reaches a pre-specified maximum allowable proportion of the total study region’s 
population, typically under 50%. Our cluster detection model treats each of the N1 resulting 
single zones as a potential cluster (region of high residual risk) or anti-cluster (region of low 
residual risk).
First, suppose that there exists no more than one cluster/anti-cluster in the study region. We 
assume the data can be explained by N1 + 1 possible configurations, where each 
configuration can be viewed as a model for y1,…, yn. The first is a null configuration of no 
clusters/anti-clusters which assumes that all areas in the study region have “null” relative 
risks that are close to 1. The remaining N1 configurations assume that one and only one 
single zone is a cluster/anti-cluster where within a single zone all areas share a common 
“non-null” relative risk, i.e., elevated or lowered risk, while all areas outside the single zone 
have null relative risks. In null areas we do not force the relative risks to be exactly 1, but 
rather assume that the relative risks arise from a “narrow” distribution that is concentrated 
close to 1, reflecting the fact that even with true null risk unmeasured confounders and data 
anomalies can still yield some variability around 1. In contrast, for non-null areas within a 
single zone, we assume they share a common relative risk that arises from a “wide” 
distribution that is more diffuse, though still centered around 1. An illustrative example of 
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null/narrow and non-null/wide relative risk distributions using two gamma distributions is 
given in Figure 8 where the respective 95% intervals are marked with dashed lines. We 
discuss the specification of the gamma distribution parameters in the next section.
We now describe how the framework is extended to allow for the possibility of more than 
one cluster/anti-cluster. Let Nj for j = 2,…, J be the number of combinations of j single 
zones that do not overlap, up to a pre-specified maximum of non-null regions J (hence, the 
maximum number of clusters/anti-clusters is J). For our examples in this paper we specify a 
maximum of J = 7 clusters/anti-clusters in the study region. Given that we only consider 
non-overlapping single zones, we assume that the relative risks in non-overlapping single 
zones are independent and arise from the wide distribution and, as with the single cluster/
anti-cluster case, all areas not included in a single zone have null relative risks. These 
configurations are the (discrete) unknown parameter of our cluster detection model; we 
denote this parameter c. The null configuration is denoted c = {0, 1} and c = {j, k} denotes a 
non-null configuration k consisting of j single zones for k = 1,…, Nj. An example of a 
configuration consisting of j = 2 single zones can be found in the Supplemental Materials. 
The posterior probability Pr(c|y1,…, yn) for all configurations c is a summary of interest of 
our model and is computed using Bayes theorem.
There are 1 + N1 + N2 + … + NJ possible configurations, that is models for the data, to 
consider. This value is very large in typical applications. For example, for the SEER data 
there are n = 887 census tracts and N1 = 117, 006 single zones. The number of multiple 
single zone configurations then grows quickly and we can only estimate, rather than 
enumerate, these quantities. For example , , and 
. Hence, it is not computationally feasible to enumerate all possible 
configurations and compute their exact posterior probabilities. Therefore, as an alternative 
we search through the space of all possible configurations using a Markov chain Monte 
Carlo (MCMC) algorithm to approximate all posterior probabilities. Details of the 
computation are in the Supplementary Materials, and the method is implemented within the 
SpatialEpi package within the R computing environment.
Likelihood and Prior
A typical choice of model for rare diseases is to assume, for a generic region with count y, y|
θ ~ Poisson(Eθ) where θ is the relative risk associated with the region and E is the expected 
number of disease.34 By assuming a conjugate Gamma(a, b) prior on θ with shape and rate 
parameters (a, b) the marginal likelihood Pr(y) is Negative Binomial . As 
previously described we have two specifications of the Gamma parameters (a, b) 
corresponding to the null and non-null distribution of relative risks described earlier: a 
narrow specification (an, bn) and a wide specification (aw, bw). These values are chosen by 
specifying two θ points with a pair of characteristics. In particular, we set the mode of the 
distribution to be θ = 1, a value reflecting no increased nor decreased risk, and we specify 
the 95th percentile of the distribution (see the Supplementary Materials for further 
discussion). For example, specifying 95th percentiles of 1.03 and 4, we have Gamma 
parameters of (an, bn) = (2976.30, 2977.30) and (aw, bw) = (2.31, 1.31) respectively, and 
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these are the choices shown in Figure 8. Furthermore the points (θL, θH) at which the two 
gamma distributions intersect are used as thresholds to declare an area’s relative risk as 
being elevated/reduced since outside the interval defined by these two points the wide 
specification has higher density. For the above choices of gamma priors the crossover points 
are (θL, θH) = (0.949, 1.052). For the null configuration c = {0, 1} all disease counts yi are 
independent with relative risks θi from the narrow specification for i = 1,…, n. For all non-
null configurations c = {j, k}, since the j single zones are independent, the likelihood for the 
data is the product of the likelihoods associated with the j single zones and the likelihoods of 
all remaining null areas.
We require a prior on the configurations c = {j, k}, with the number of clusters/anti-clusters 
being j, and k indexing the configurations for that j. We assign a mass of π0 = Pr(c = {0, 1}) 
for the prior on the null, with a typical figure being 0.95 or 0.99, since a priori we expect the 
chance of clusters to be small. The remaining mass of 1 − π0 needs to be spread over the 
remaining configurations c = {j, k} for j = 1,…, J, k = 1,…, Nj. Within each j, i.e. for each 
number of clusters/anti-clusters, we take each configuration to be equally likely, i.e. 
, where τ is the number of clusters/anti-clusters. It only remains to 
distribute 1 − π0 over j = 1,…, J. Recall that each set of j clusters within a particular 
configuration must be non-overlapping. For a particular j, let qj be the probability that a 
randomly selected set of j clusters are non-overlapping. For example, for j = 2, q2 is the 
probability that two of the randomly selected N2 possible single zones are non-overlapping. 
One may then take
so that the marginal prior on the number of clusters/anti-clusters is implied by our choice of 
the prior on the null, and the set of decreasing probabilities on increasing numbers of 
clusters/anti-clusters. This produces a set of prior probabilities that decrease monotonically 
from J = 1, in a relatively natural fashion. As an illustration, with the Puget Sound study 
geography, the probabilities for j = 0,…, J we obtain from this prescription are 0.950, 0.034, 
0.013, 0.003, 2.941 × 10−4, 1.993 × 10−5, 1.027 × 10−6, and 3.029 × 10−8. There are many 
ways we could specify the set of J + 1 probabilities, and we encourage examining the 
sensitivity of the results to different choices (see later for examples). For example, we may 
also spread the probability of a non-null configuration 1 − π0 equally over j = 1,…, J.
Posterior Probabilities
Each configuration c = {j, k} for j ≥ 1 is made up of j single, non-overlapping zones. The 
posterior probability for the null configuration is simply
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For j ≥ 1:
where i ∈ c denotes all the areas included in any of j single zones that form configuration c = 
{j, k}. In other words, all areas included in any of the single zones follow the non-null model 
where areas within a common single zone share a common relative risk from the wide prior 
and all remaining areas are independent with relative risks from the narrow prior. See 
Supplementary Materials for more details on this derivation.
It is difficult to make statements on the occurrence of clusters/anti-clusters based on the 
posterior probabilities of individual configurations given the large number of configurations 
to consider, many of which are only minor variations of each other. As an alternative 
measure, we may calculate the posterior probability of cluster membership for each area i. 
For a non-null configuration c = {j, k} with area i included in one of the j single zones, we 
evaluate the posterior probability of that single zone’s relative risk being “elevated”, where 
elevated indicates higher than the high crossover point θH. Analogously we can define the 
posterior probability of anti-cluster membership for area i using the lower crossover point 
θL. Furthermore, before seeing the data we can evaluate the prior probability of cluster 
membership for each area i using the prior distribution of the relative risk. Another summary 
measure of interest is the posterior probability of the number of clusters/anti-clusters in the 
data. For τ = j clusters/anti-clusters we have
which sums the posterior probabilities of all configurations with τ single zones. Of particular 
interest will be the τ = 0 case corresponding to no clusters/anti-clusters.
Results
Bayesian Analysis for Brain Cancer
We perform the Bayesian analyses with the maximum proportion of the population a single 
zone can contain being 15%, wide (aw, bw) = (2.31, 1.31) and narrow (an, bn) = (2976.30, 
2977.30) specifications of the Gamma parameters, as shown in Figure 8, a prior probability 
π0 = 0.95 of no clusters/anti-clusters, and a maximum number of clusters/anti-clusters of J = 
7.
In Figure 9 we present the results for brain cancer using the income unadjusted expected 
counts in the left column and income adjusted expected counts in the right column. The 
results are not inconsistent with the multiple cluster scan statistic results, with both analyses 
giving very little evidence of brain cancer clusters, with the highest posterior probabilities of 
cluster membership being less than 0.006. In Figure 10 we present a barplot of the prior 
probabilities of clusters/anti-clusters for j = 0,…, 7, along with the posteriors probabilities 
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with and without adjustment for income. The posterior probability of no clusters/anti-
clusters is approximately 0.99 in both cases, which is higher than the prior probability of π0 
= 0.95. In Figure 11 we present a plot of the sensitivity of the posterior probabilities on the 
number of clusters/anti-clusters as a function of the specification for π0, the prior mass 
placed on the null configuration. The calculations for this plot can be carried out without re-
running the analysis (for details, see Supplemental Materials). Tracing horizontal lines 
across the plot give the set of posterior probabilities for that π0 value. There is a relative 
insensitivity to π0 in both plots, with only very low (and unrealistic) values of π0 giving even 
a single cluster/anti-cluster. In the Supplementary Materials we further investigate prior 
sensitivity to the specification of the narrow/wide components and an alternative prior on the 
number of clusters/anti-clusters (uniform on 1,…, J). There is little sensitivity to the 
different priors, and for brain cancer we conclude there is little evidence for clusters in the 
Puget Sound region, at the geographical scale at which we have data available.
Bayesian Analysis for Breast Cancer
In Figure 12 we present the results for breast cancer using the income unadjusted expected 
counts in the left column and income adjusted expected counts in the right column. We 
observe a large number of areas with high posterior probability of cluster membership in 
Seattle and the Kirkland, Redmond, and Bellevue suburbs. These probabilities diminish in 
magnitude when using the income adjusted expected counts, indicating that a large 
component of the high relative risks in these areas has been absorbed by income. As we see 
in Figure 13, there is a large mass of posterior probability (94%) of j = 4, 5 clusters/anti-
clusters when ignoring income information that shifts towards j = 0 once income 
information is incorporated. After adjustment there is 73% posterior probability on the null, 
with the majority of the remaining probability falling on 1 or 2 clusters/anti-clusters. There 
remains a single area in Tacoma with a relatively high posterior probability of 0.201. The 
second and third clusters indicated by the scan statistic method (Figure 7) do not have high 
posterior probabilities associated with them. The heat map in Figure 14 illustrates the 
sensitivity of the posterior on the number of clusters/anti-clusters to the prior on the null, π0. 
In the case of breast cancer adjusted for income, the results are almost entirely insensitive to 
the choice of π0. After incorporating income however, the posterior probabilities now vary 
more depending on the choice of π0. Since higher values of π0 correspond to higher prior 
skepticism at the existence of clusters/anti-clusters, the bulk of the posterior probabilities 
shifts towards j = 0. Additional summaries under different priors are given in the 
Supplementary Materials.
As discussed earlier, there are many well-documented risk factors for breast cancer, and we 
would expect many of these risk factors to have geographical structure. Unfortunately, as is 
usually the case in studies such as this based on aggregated count data, information on these 
risk factors is not available. Many of these risk factors will be associated with income, which 
explains why the number of clusters decreased when an area-level measure of income was 
included. This adjustment is clearly very crude and further analyses of breast cancer 
incidence in our study region would preferably be carried out using individual-level data 
with information on risk factors. Another important issue for breast cancer is screening. 
Screening rates vary geographically and we would expect those areas with high screening 
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rates to have more breast cancer diagnoses even if the underlying risk is the same as areas 
with lower screening rates. This is supported by a plot of SMR versus screening rate (at the 
county level), included in the Supplementary Materials.
Discussion
Much like the multiple cluster Kulldorff method,6 our Bayesian model constructs a set of 
single zones and treats each of them as potential clusters/anti-clusters. However, our method 
allows us to formally model the existence of more than one cluster by combining a number j 
of single zones to form configurations. These configurations, in particular the null 
configuration of no clusters/anti-clusters, are used as models to explain the observations and 
are the unknown parameters of our model to which we associate prior and posterior 
probabilities. By taking a Bayesian approach, our model accounts for sample size and 
power.9;10;13
While our method yields qualitatively similar results as the multiple cluster Kulldorff 
method, since our model allows for simultaneous modeling of more than one cluster/anti-
cluster we obtain probabilities of cluster membership which are directly comparable 
between areas. This is in contrast to the multiple cluster Kulldorff method which considers 
only the most significant cluster, drops (if any) the most significant cluster, and iterates the 
procedure. The resulting p-values are difficult to interpret as they are sequential in nature 
and all resulting claims of significance based on them do not incorporate notions of sample 
size or power.
The computation for the Bayesian model is far greater than that for typical scan statistics, 
but the biggest difficulty in routinely using the Bayesian approach we have described is the 
need to specify prior distributions. In practice, as we have illustrated for brain and breast 
cancer, one should carry out sensitivity to the prior distribution. We would encourage the use 
of Kulldorff’s scan statistic, in particular at the early stages of a cluster detection exercise, 
but we believe that the Bayesian approach we have described provides valuable additional 
information, foremost explicit posterior probabilities of cluster membership for each area, 
and a coherent way of handling multiple clusters.
The methods described in the paper is implemented in the R package SpatialEpi. An 
example of its application to the often studied upstate New York leukemia dataset can be 
found at https://github.com/rudeboybert/SpatialEpi.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Study region with Seattle (solid line) and Tacoma (dashed line) metropolitan regions 
highlighted and the city of Mount Vernon marked with a dot.
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Figure 2. 
Maps of income unadjusted (left column) and income adjusted (right column) expected 
counts of brain cancer.
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Figure 3. 
Maps of income unadjusted (left column) and income adjusted (right column) standardized 
morbidity ratios for brain cancer.
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Figure 4. 
Maps of income unadjusted (left column) and income adjusted (right column) multiple 
cluster scan statistic results for brain cancer.
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Figure 5. 
Maps of income unadjusted (left column) and income adjusted (right column) expected 
counts of breast cancer.
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Figure 6. 
Maps of income unadjusted (left column) and income adjusted (right column) standardized 
morbidity ratios for breast cancer.
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Figure 7. 
Maps of income unadjusted (left column) and income adjusted (right column) multiple 
cluster scan statistic results for breast cancer.
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Figure 8. 
Wide and narrow distributions on the relative risk. Under the null (no clusters/anti-clusters), 
relative risks θ are assumed to arise from the narrow prior, so that there is still a small 
amount of “wobble” about 1. Under the alternative (at least one cluster/anti-cluster), the 
relative risks are assumed to arise from the wide prior, so that there is greater variation. Note 
that the θ scale is logarithmic.
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Figure 9. 
Maps of income unadjusted (left column) and income adjusted (right column) posterior 
probabilities of brain cancer cluster membership.
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Figure 10. 
Prior/posterior probabilities of the number of brain cancer clusters/anti-clusters.
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Figure 11. 
Sensitivity of posterior probabilities of the number of brain cancer clusters/anti-clusters to 
π0. Tracing horizontal lines across the plot give the set of posterior probabilities for that π0 
value.
Kim and Wakefield Page 24
Epidemiology. Author manuscript; available in PMC 2016 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 12. 
Maps of income unadjusted (left column) and income adjusted (right column) posterior 
probabilities of breast cancer cluster membership.
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Figure 13. 
Prior/posterior probabilities of the number of breast cancer clusters/anti-clusters.
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Figure 14. 
Sensitivity of posterior probabilities of the number of breast cancer clusters/anti-clusters to 
π0. Tracing horizontal lines across the plot give the set of posterior probabilities for that π0 
value.
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